Bladder Cancer Trial, Recruiting NCT06662071 Sponsor: Qilu Hospital of Shandong University Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT06662071
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old (any gender)
  • You have been diagnosed with intermediate-risk or high-risk bladder cancer that has not grown into the bladder muscle, and your doctor has recommended bladder wash-out (instillation) treatment
  • You have not previously had bladder wash-out treatment, other than a one-time treatment given immediately after surgery
  • You are generally able to carry out daily activities, with little to no limitation from your illness (confirm with trial site)
  • You are able and willing to follow the trial schedule, attend follow-up appointments, and report any side effects as directed by the study team
  • You are willing to take part voluntarily, understand what the study involves, and have signed a consent form

Who may not be able to join:

  • Your bladder was accidentally punctured during surgery, or you currently have heavy visible blood in your urine, a serious bladder inflammation caused by chemicals, or a urinary tract infection
  • You have a weakened or damaged immune system — for example, due to HIV/AIDS, or because you are taking medication that suppresses the immune system, or you have had radiotherapy
  • You have a known allergy or sensitivity to the study drug or any of its ingredients
  • You have been taking hormone-based medications long-term, or you have a history of drug misuse or dependence
  • You are pregnant, breastfeeding, or planning to become pregnant in the near future
  • Your blood test results, liver or kidney function, or blood clotting results are outside acceptable ranges — this includes low counts of certain blood cells, low haemoglobin (indicating possible anaemia), poor kidney function, or abnormal clotting levels (confirm with trial site for specific values)
  • You have been diagnosed with, or currently have, a bone marrow disorder called myelodysplastic syndrome (MDS) or a type of blood cancer called acute myeloid leukaemia (AML)
  • You have a confirmed history of a serious neurological or mental health condition, such as epilepsy or dementia
  • You have serious ongoing health conditions — such as severely uncontrolled high blood pressure, diabetes, or thyroid disease — that could put you at risk or affect your ability to complete the study
  • You have other serious illnesses, very abnormal lab results, or personal/social circumstances that could affect your safety or the collection of study data
  • You have an active infection being treated, heart failure, unstable chest pain (angina), or an irregular heartbeat that is not under control
  • The study doctor feels, for any other reason, that this trial is not appropriate for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18560084873

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
30 September 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

One-year RFS and Three-year RFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov